• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中央静脉征在多发性硬化症鉴别诊断中的应用]

[The central vein sign in the differential diagnosis of multiple sclerosis].

作者信息

Belov S E, Boyko A N, Dolgushin M B

机构信息

Pirogov Russian National Research Medical University, Moscow, Russia.

Federal Center for Brain Research and Neurotechnology, Moscow, Russia.

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(7. Vyp. 2):58-65. doi: 10.17116/jnevro202412407258.

DOI:10.17116/jnevro202412407258
PMID:39175241
Abstract

OBJECTIVE

To carry out a clinical and radiological assessment of the central vein sign (CVS) as a diagnostic marker for multiple sclerosis (MS) and other demyelinating and non-demyelinating diseases with focal brain damage, using clinical and laboratory examination data, as well as MRI.

MATERIAL AND METHODS

The results of clinical and neuroradiological examination of 107 patients diagnosed with MS or with other diseases accompanied by focal brain damage according to MRI data were analyzed.

RESULTS

CVS is a sensitive but low-specific diagnostic marker of MS. According to our data, the sensitivity and specificity of 40 and 50% of the threshold of perivenular lesions in the diagnosis of MS are the same and amount to 100% and 39.4%, respectively. Neither the type of MS course, nor the severity of the course, nor the intake of DMT (disease modifying treatment), affect the proportion of foci with CVS. The spread of the proportion of foci with CVS in patients with MS was 60-100%. The proportion of foci with CVS is below 40 and 50% of the threshold in patients with demyelinating and non-demyelinating diseases (NMOSD, migraine, systemic lupus erythematosus, Susak disease, CLIPPERS), which allows for differential diagnosis with MS. The proportion of foci with CVS comparable to MS in patients with acute disseminated encephalomyelitis, small vessel disease, as well as in patients with radiologically isolated syndrome does not allow using this symptom in the differential diagnosis of these conditions.

CONCLUSION

The use of CVS as a diagnostic marker of MS is possible only in combination with the already existing diagnostic criteria of MS.

摘要

目的

利用临床和实验室检查数据以及磁共振成像(MRI),对中央静脉征(CVS)作为多发性硬化(MS)以及其他伴有局灶性脑损伤的脱髓鞘和非脱髓鞘疾病的诊断标志物进行临床和影像学评估。

材料与方法

分析了107例根据MRI数据诊断为MS或患有其他伴有局灶性脑损伤疾病的患者的临床和神经放射学检查结果。

结果

CVS是MS的一个敏感但特异性较低的诊断标志物。根据我们的数据,在MS诊断中,静脉周围病变阈值的40%和50%时的敏感性和特异性相同,分别为100%和39.4%。MS病程类型、病程严重程度以及疾病修正治疗(DMT)的使用均不影响出现CVS病灶的比例。MS患者中出现CVS病灶的比例范围为60%-100%。在脱髓鞘和非脱髓鞘疾病(视神经脊髓炎谱系疾病、偏头痛、系统性红斑狼疮、苏萨克病、慢性淋巴细胞性炎症伴脑桥血管周围强化症)患者中,出现CVS病灶的比例低于阈值的40%和50%,这有助于与MS进行鉴别诊断。在急性播散性脑脊髓炎、小血管疾病以及放射学孤立综合征患者中,出现CVS病灶的比例与MS相当,因此无法利用这一症状对这些疾病进行鉴别诊断。

结论

仅将CVS作为MS的诊断标志物使用时,必须结合现有的MS诊断标准。

相似文献

1
[The central vein sign in the differential diagnosis of multiple sclerosis].[中央静脉征在多发性硬化症鉴别诊断中的应用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(7. Vyp. 2):58-65. doi: 10.17116/jnevro202412407258.
2
Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.中央静脉征作为多发性硬化症诊断影像学生物标志物的评估。
JAMA Neurol. 2019 Dec 1;76(12):1446-1456. doi: 10.1001/jamaneurol.2019.2478.
3
The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T study.多发性硬化症诊断“红旗”患者的“中央静脉征”:一项前瞻性多中心3T研究。
Mult Scler. 2020 Apr;26(4):421-432. doi: 10.1177/1352458519876031. Epub 2019 Sep 19.
4
Central Vein Sign, Cortical Lesions, and Paramagnetic Rim Lesions for the Diagnostic and Prognostic Workup of Multiple Sclerosis.中央静脉征、皮质病变和顺磁性边缘病变在多发性硬化的诊断和预后评估中的作用。
Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200253. doi: 10.1212/NXI.0000000000200253. Epub 2024 May 24.
5
Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty.单测试诊断多发性硬化症(STAR-MS):一项前瞻性试点研究评估中央静脉征在诊断不确定情况下预测多发性硬化症的准确性。
Mult Scler. 2020 Apr;26(4):433-441. doi: 10.1177/1352458519882282. Epub 2019 Oct 31.
6
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis.多发性硬化症中皮质病变和中央静脉征的诊断性能。
JAMA Neurol. 2024 Feb 1;81(2):143-153. doi: 10.1001/jamaneurol.2023.4737.
7
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.中央静脉征及其临床评估在多发性硬化诊断中的应用:北美多发性硬化影像学合作组的共识声明。
Nat Rev Neurol. 2016 Dec;12(12):714-722. doi: 10.1038/nrneurol.2016.166. Epub 2016 Nov 11.
8
The central vein sign in multiple sclerosis patients with vascular comorbidities.血管共病多发性硬化症患者的中央静脉征。
Mult Scler. 2021 Jun;27(7):1057-1065. doi: 10.1177/1352458520943785. Epub 2020 Aug 4.
9
The diagnostic value of the central vein sign in radiologically isolated syndrome.中央静脉征在放射孤立综合征中的诊断价值。
Ann Clin Transl Neurol. 2024 Mar;11(3):662-672. doi: 10.1002/acn3.51986. Epub 2024 Jan 8.
10
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.中央静脉征:一项用于前瞻性多中心试验的多发性硬化症(CAVS-MS)研究方案中的诊断生物标志物。
Neuroimage Clin. 2021;32:102834. doi: 10.1016/j.nicl.2021.102834. Epub 2021 Sep 23.